Cargando…

The dipeptidyl peptidase-4 (DPP-4) inhibitor teneligliptin functions as antioxidant on human endothelial cells exposed to chronic hyperglycemia and metabolic high-glucose memory

Dipeptidyl peptidase-4 inhibitors are widely used in type 2 diabetes. Endothelium plays a crucial role maintaining vascular integrity and function. Chronic exposure to high glucose drives to endothelial dysfunction generating oxidative stress. Teneligliptin is a novel dipeptidyl peptidase-4 inhibito...

Descripción completa

Detalles Bibliográficos
Autores principales: Pujadas, Gemma, De Nigris, Valeria, Prattichizzo, Francesco, La Sala, Lucia, Testa, Roberto, Ceriello, Antonio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5435779/
https://www.ncbi.nlm.nih.gov/pubmed/27530507
http://dx.doi.org/10.1007/s12020-016-1052-0
_version_ 1783237276584640512
author Pujadas, Gemma
De Nigris, Valeria
Prattichizzo, Francesco
La Sala, Lucia
Testa, Roberto
Ceriello, Antonio
author_facet Pujadas, Gemma
De Nigris, Valeria
Prattichizzo, Francesco
La Sala, Lucia
Testa, Roberto
Ceriello, Antonio
author_sort Pujadas, Gemma
collection PubMed
description Dipeptidyl peptidase-4 inhibitors are widely used in type 2 diabetes. Endothelium plays a crucial role maintaining vascular integrity and function. Chronic exposure to high glucose drives to endothelial dysfunction generating oxidative stress. Teneligliptin is a novel dipeptidyl peptidase-4 inhibitor with antioxidant properties. This study is aimed to verify a potential protective action of teneligliptin in endothelial cells exposed to high glucose. Human umbilical vein endothelial cells were cultured under normal (5 mmol/L) or high glucose (25 mmol/L) during 21 days, or at high glucose during 14 days followed by 7 days at normal glucose, to reproduce the high-metabolic memory state. During this period, different concentrations of teneligliptin (0.1, 1.0 and 3.0 µmol/L) or sitagliptin (0.5 µmol/L) were added to cells. Ribonucleic acid and protein expression were assessed for antioxidant response, proliferation, apoptosis and endoplasmic reticulum stress markers. Teneligliptin promotes the antioxidant response in human umbilical vein endothelial cells, reducing ROS levels and inducing Nrf2-target genes messenger ribonucleic acid expression. Teneligliptin, but not sitagliptin, reduces the expression of the nicotine amide adenine dinucleotide phosphate oxidase regulatory subunit P22 (−phox), however, both blunt the high glucose-induced increase of TXNIP. Teneligliptin improves proliferation rates in human umbilical vein endothelial cells exposed to high glucose, regulating the expression of cell-cycle inhibitors markers (P53, P21 and P27), and reducing proapoptotic genes (BAX and CASP3), while promotes BCL2 expression. Teneligliptin ameliorates high glucose-induced endoplasmic reticulum stress reducing the expression of several markers (BIP, PERK, ATF4, CHOP, IRE1a and ATF6). Teneligliptin has antioxidant properties, ameliorates oxidative stress and apoptotic phenotype and it can overcome the metabolic memory effect, induced by chronic exposure to high glucose in human endothelial cells.
format Online
Article
Text
id pubmed-5435779
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-54357792017-05-31 The dipeptidyl peptidase-4 (DPP-4) inhibitor teneligliptin functions as antioxidant on human endothelial cells exposed to chronic hyperglycemia and metabolic high-glucose memory Pujadas, Gemma De Nigris, Valeria Prattichizzo, Francesco La Sala, Lucia Testa, Roberto Ceriello, Antonio Endocrine Original Article Dipeptidyl peptidase-4 inhibitors are widely used in type 2 diabetes. Endothelium plays a crucial role maintaining vascular integrity and function. Chronic exposure to high glucose drives to endothelial dysfunction generating oxidative stress. Teneligliptin is a novel dipeptidyl peptidase-4 inhibitor with antioxidant properties. This study is aimed to verify a potential protective action of teneligliptin in endothelial cells exposed to high glucose. Human umbilical vein endothelial cells were cultured under normal (5 mmol/L) or high glucose (25 mmol/L) during 21 days, or at high glucose during 14 days followed by 7 days at normal glucose, to reproduce the high-metabolic memory state. During this period, different concentrations of teneligliptin (0.1, 1.0 and 3.0 µmol/L) or sitagliptin (0.5 µmol/L) were added to cells. Ribonucleic acid and protein expression were assessed for antioxidant response, proliferation, apoptosis and endoplasmic reticulum stress markers. Teneligliptin promotes the antioxidant response in human umbilical vein endothelial cells, reducing ROS levels and inducing Nrf2-target genes messenger ribonucleic acid expression. Teneligliptin, but not sitagliptin, reduces the expression of the nicotine amide adenine dinucleotide phosphate oxidase regulatory subunit P22 (−phox), however, both blunt the high glucose-induced increase of TXNIP. Teneligliptin improves proliferation rates in human umbilical vein endothelial cells exposed to high glucose, regulating the expression of cell-cycle inhibitors markers (P53, P21 and P27), and reducing proapoptotic genes (BAX and CASP3), while promotes BCL2 expression. Teneligliptin ameliorates high glucose-induced endoplasmic reticulum stress reducing the expression of several markers (BIP, PERK, ATF4, CHOP, IRE1a and ATF6). Teneligliptin has antioxidant properties, ameliorates oxidative stress and apoptotic phenotype and it can overcome the metabolic memory effect, induced by chronic exposure to high glucose in human endothelial cells. Springer US 2016-08-16 2017 /pmc/articles/PMC5435779/ /pubmed/27530507 http://dx.doi.org/10.1007/s12020-016-1052-0 Text en © The Author(s) 2016 This article is distributed under the terms of the Creative     Commons      Attribution       4.0      International      License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Original Article
Pujadas, Gemma
De Nigris, Valeria
Prattichizzo, Francesco
La Sala, Lucia
Testa, Roberto
Ceriello, Antonio
The dipeptidyl peptidase-4 (DPP-4) inhibitor teneligliptin functions as antioxidant on human endothelial cells exposed to chronic hyperglycemia and metabolic high-glucose memory
title The dipeptidyl peptidase-4 (DPP-4) inhibitor teneligliptin functions as antioxidant on human endothelial cells exposed to chronic hyperglycemia and metabolic high-glucose memory
title_full The dipeptidyl peptidase-4 (DPP-4) inhibitor teneligliptin functions as antioxidant on human endothelial cells exposed to chronic hyperglycemia and metabolic high-glucose memory
title_fullStr The dipeptidyl peptidase-4 (DPP-4) inhibitor teneligliptin functions as antioxidant on human endothelial cells exposed to chronic hyperglycemia and metabolic high-glucose memory
title_full_unstemmed The dipeptidyl peptidase-4 (DPP-4) inhibitor teneligliptin functions as antioxidant on human endothelial cells exposed to chronic hyperglycemia and metabolic high-glucose memory
title_short The dipeptidyl peptidase-4 (DPP-4) inhibitor teneligliptin functions as antioxidant on human endothelial cells exposed to chronic hyperglycemia and metabolic high-glucose memory
title_sort dipeptidyl peptidase-4 (dpp-4) inhibitor teneligliptin functions as antioxidant on human endothelial cells exposed to chronic hyperglycemia and metabolic high-glucose memory
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5435779/
https://www.ncbi.nlm.nih.gov/pubmed/27530507
http://dx.doi.org/10.1007/s12020-016-1052-0
work_keys_str_mv AT pujadasgemma thedipeptidylpeptidase4dpp4inhibitorteneligliptinfunctionsasantioxidantonhumanendothelialcellsexposedtochronichyperglycemiaandmetabolichighglucosememory
AT denigrisvaleria thedipeptidylpeptidase4dpp4inhibitorteneligliptinfunctionsasantioxidantonhumanendothelialcellsexposedtochronichyperglycemiaandmetabolichighglucosememory
AT prattichizzofrancesco thedipeptidylpeptidase4dpp4inhibitorteneligliptinfunctionsasantioxidantonhumanendothelialcellsexposedtochronichyperglycemiaandmetabolichighglucosememory
AT lasalalucia thedipeptidylpeptidase4dpp4inhibitorteneligliptinfunctionsasantioxidantonhumanendothelialcellsexposedtochronichyperglycemiaandmetabolichighglucosememory
AT testaroberto thedipeptidylpeptidase4dpp4inhibitorteneligliptinfunctionsasantioxidantonhumanendothelialcellsexposedtochronichyperglycemiaandmetabolichighglucosememory
AT cerielloantonio thedipeptidylpeptidase4dpp4inhibitorteneligliptinfunctionsasantioxidantonhumanendothelialcellsexposedtochronichyperglycemiaandmetabolichighglucosememory
AT pujadasgemma dipeptidylpeptidase4dpp4inhibitorteneligliptinfunctionsasantioxidantonhumanendothelialcellsexposedtochronichyperglycemiaandmetabolichighglucosememory
AT denigrisvaleria dipeptidylpeptidase4dpp4inhibitorteneligliptinfunctionsasantioxidantonhumanendothelialcellsexposedtochronichyperglycemiaandmetabolichighglucosememory
AT prattichizzofrancesco dipeptidylpeptidase4dpp4inhibitorteneligliptinfunctionsasantioxidantonhumanendothelialcellsexposedtochronichyperglycemiaandmetabolichighglucosememory
AT lasalalucia dipeptidylpeptidase4dpp4inhibitorteneligliptinfunctionsasantioxidantonhumanendothelialcellsexposedtochronichyperglycemiaandmetabolichighglucosememory
AT testaroberto dipeptidylpeptidase4dpp4inhibitorteneligliptinfunctionsasantioxidantonhumanendothelialcellsexposedtochronichyperglycemiaandmetabolichighglucosememory
AT cerielloantonio dipeptidylpeptidase4dpp4inhibitorteneligliptinfunctionsasantioxidantonhumanendothelialcellsexposedtochronichyperglycemiaandmetabolichighglucosememory